Is Dr Agarwal's Eye Hospital Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Dr Agarwal's Eye Hospital Ltd (526783.BO) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Dr Agarwal's Eye Hospital Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Dr Agarwal's Eye Hospital Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Dr Agarwal's Eye Hospital Ltd?

Muslim investors may consider investing in Dr Agarwal's Eye Hospital Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Dr Agarwal's Eye Hospital Ltd classified as HALAL?

Musaffa determines the Shariah status of Dr Agarwal's Eye Hospital Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Dr Agarwal's Eye Hospital Ltd updated?

The Shariah compliance status of Dr Agarwal's Eye Hospital Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Dr Agarwal's Eye Hospital Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Dr Agarwal's Eye Hospital Ltd?

You can check the latest Shariah compliance status of Dr Agarwal's Eye Hospital Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Dr Agarwal's Eye Hospital Ltd 526783.BO

₹5,040.00 ₹60.05 (1.18%) 1D

Last Updated: May 15, 12:00 AM·BSE

526783.BO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 26, 2026

Report Source: 2026 3rd Quarter Report

Dr Agarwal's Eye Hospital Ltd. Stock Analysis 526783.BO

India Health Care Micro Cap Report: Q3, 2026

Dr. Agarwal's Eye Hospital Ltd. operates as an eye hospital, which engages in the provision of eye care solutions. The firm provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. The company also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The firm provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Pondicherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.

Key Statistics of Dr Agarwal's Eye Hospital Ltd (526783.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹5,040.00₹5,139.60

Today's Open

₹5,100.05

Volume

115.00

P/E Ratio (TTM)

42.17

52 Week Range

₹4,000.00₹6,392.00

Market Cap

23.51B

Avg. Volume

680.09

Dividend Yield

0.05%

Financial Metrics & Statements of Dr Agarwal's Eye Hospital Ltd (526783.BO)

FAQ's for Dr Agarwal's Eye Hospital Ltd (526783.BO)

According to Musaffa’s Shariah screening methodology, Dr Agarwal's Eye Hospital Ltd (526783.BO) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.